CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue159,20181,32150,286
Cost of Revenue3,5542,0581,361
Gross Profit155,64779,26348,925
Operating Expenses
Research Development40,37623,84415,419
Selling General and Administrative62,41645,24036,949
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss52,85510,179-3,443
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes52,85510,179-3,443
Interest Expense492,0392,965
Income Before Tax52,8068,140-6,408
Income Tax Expense-76,316--
Minority Interest---
Net Income From Continuing Ops129,1228,140-6,408
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income129,1228,140-6,408
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares129,1228,140-6,408